GO:0045124

BP

regulation of bone resorption

Any process that modulates the frequency, rate or extent of bone tissue loss (resorption).

BGLAP, ITGB3, CSF1R, S1PR1, PDK4

GO:0045128

BP

negative regulation of reciprocal meiotic recombination

Any process that decreases the frequency, rate or extent of recombination during meiosis. Reciprocal meiotic recombination is the cell cycle process in which double strand breaks are formed and repaired through a double Holliday junction intermediate.

MSH2

GO:0045132

BP

meiotic chromosome segregation

The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets during M phase of the meiotic cell cycle.

SMC2, SGOL1, WAPL, SMC4

GO:0045136

BP

development of secondary sexual characteristics

The process whose specific outcome is the progression of the secondary sexual characteristics over time, from their formation to the mature structures. In humans, these include growth of axillary, chest, and pubic hair, voice changes, testicular/penile enlargement, breast development and menstrual periods. Development occurs in response to sex hormone secretion.

B4GALT1, BAX

GO:0045141

BP

meiotic telomere clustering

The cell cycle process in which the dynamic reorganization of telomeres occurs in early meiotic prophase, during which meiotic chromosome ends are gathered in a bouquet arrangement at the inner surface of the nuclear envelope proximal to the spindle pole body. This plays an important role in progression through meiosis and precedes synapsis.

MLH1, TERF1, UBE2B

GO:0045143

BP

homologous chromosome segregation

The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the first division of the meiotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner; this pairing off, referred to as synapsis, permits genetic recombination. One homolog (both sister chromatids) of each morphologic type goes into each of the resulting chromosome sets.

PTTG1, PLK1, ESPL1

GO:0045162

BP

clustering of voltage-gated sodium channels

The process in which voltage-gated sodium channels become localized together in high densities. In animals, nodes of Ranvier differ dramatically from internodal axonal regions in very high densities of voltage-dependent sodium (Nav) channels responsible for the rapid, inward ionic currents that produce membrane depolarization.

GLDN, NRCAM, SPTBN4

GO:0045163

BP

clustering of voltage-gated potassium channels

The process in which voltage-gated potassium channels become localized together in high densities. In animals, voltage-gated potassium (Kv) channels are clustered beneath the myelin sheath in regions immediately adjacent to paranodes, called juxtaparanodes, and along the inner mesaxon within the internode.

KCNIP2

GO:0045165

BP

cell fate commitment

The commitment of cells to specific cell fates and their capacity to differentiate into particular kinds of cells. Positional information is established through protein signals that emanate from a localized source within a cell (the initial one-cell zygote) or within a developmental field.

SOX12, SPRY2, WNT2, BMP2, TAL1, GAP43, FGFR2, PPARG, WNT5A, GATA4, GAS1, WNT3, SOX8, ERBB4, SMAD2, GATA6, WNT2B, WNT5B, TRPS1, WNT6

GO:0045176

BP

apical protein localization

Any process in which a protein is transported to, or maintained in, apical regions of the cell.

ARF4, MAL, RDX, SHROOM2, DLG5, SHROOM3, GOPC

GO:0045184

BP

establishment of protein localization

The directed movement of a protein to a specific location.

CHMP2A, RAP2A, ITGA2, FLNA, RDX, LIMS1, PLK1, IST1, VCP, DLG4, MDM2, ANK3, KPNB1, KIF14, CEP55, PHLDB2, NLGN1, WBP2, VIMP, SMYD3, CRIPT, CORO1C

GO:0045186

BP

zonula adherens assembly

Assembly of the zonula adherens, a cell-cell adherens junction which forms a continuous belt near the apex of epithelial cells.

DLG5

GO:0045187

BP

regulation of circadian sleep/wake cycle, sleep

Any process that modulates the frequency, rate or extent of sleep; a readily reversible state of reduced awareness and metabolic activity that occurs periodically in many animals.

PTGDS

GO:0045188

BP

regulation of circadian sleep/wake cycle, non-REM sleep

Any process that modulates the frequency, rate or extent of non-rapid eye movement sleep.

IL6

GO:0045190

BP

isotype switching

The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus.

NBN, RNF8, ERCC1, CD40LG, MLH1, MSH2, MSH6, EXOSC6, EXOSC3, EXO1

GO:0045191

BP

regulation of isotype switching

Any process that modulates the frequency, rate or extent of isotype switching.

IL10, SUPT6H

GO:0045197

BP

establishment or maintenance of epithelial cell apical/basal polarity

Any cellular process that results in the specification, formation or maintenance of the apicobasal polarity of an epithelial cell.

ARF4, PRKCI, DLG4, DLG1, ILK, DLG5

GO:0045198

BP

establishment of epithelial cell apical/basal polarity

The specification and formation of the apicobasal polarity of an epithelial cell.

WNT5A, TCF15, PTK7

GO:0045199

BP

maintenance of epithelial cell apical/basal polarity

The maintenance of the apicobasal polarity of an epithelial cell.

WDR1, LHX2, PDZD11, LIN7B, LIN7C

GO:0045200

BP

establishment of neuroblast polarity

The specification and formation of the apicobasal polarity of a neuroblast cell, a progenitor of the central nervous system.

FGF13, DOCK7

GO:0045204

BP

MAPK export from nucleus

The directed movement of a MAP kinase from the nucleus to the cytoplasm.

DUSP16

GO:0045209

BP

MAPK phosphatase export from nucleus, leptomycin B sensitive

Leptomycin B-sensitive movement of a MAPK phosphatase from the nucleus to the cytoplasm.

DUSP16

GO:0045210

BP

FasL biosynthetic process

The chemical reactions and pathways resulting in the formation of fas ligand (FasL or CD95L), an antigen originally found to be expressed on the cell surface of activated human T-lymphocytes and B-lymphocytes and a variety of malignant human lymphoid cell lines.

PHLDA1

GO:0045213

BP

neurotransmitter receptor metabolic process

The chemical reactions and pathways involving neurotransmitter receptors.

NRG1

GO:0045214

BP

sarcomere organization

The myofibril assembly process that results in the organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.

WDR1, LDB3, BMP10, ITGB1, KRT8, KRT19, TPM1, PRKAR1A, CAPN3, ACTN2, ACTG1, ANKRD1, TTN

GO:0045216

BP

cell-cell junction organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.

CLDN1, TGFB1, NF2, PRKCI, TGFB2, RAC1, CXADR, SMAD3, OCLN, NLGN4X, MARVELD3, CCM2

GO:0045217

BP

cell-cell junction maintenance

The maintenance of junctions between cells.

CSF1R, PARD6A

GO:0045218

BP

zonula adherens maintenance

Maintaining the zonula adherens junction, the cell-cell adherens junction formed near the apex of epithelial cells.

CAMSAP3

GO:0045221

BP

negative regulation of FasL biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of FasL.

JAK3

GO:0045225

BP

negative regulation of CD4 biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of CD4.

ACOT8

GO:0045226

BP

extracellular polysaccharide biosynthetic process

The chemical reactions and pathways resulting in the formation of polysaccharides used in extracellular structures.

HAS2

GO:0045292

BP

mRNA cis splicing, via spliceosome

The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.

NCBP1, RBM22

GO:0045321

BP

leukocyte activation

A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor.

EDN1, TOLLIP

GO:0045324

BP

late endosome to vacuole transport

The directed movement of substances from late endosomes to the vacuole. In yeast, after transport to the prevacuolar compartment, endocytic content is delivered to the late endosome and on to the vacuole. This pathway is analogous to endosome to lysosome transport.

PIK3R4

GO:0045329

BP

carnitine biosynthetic process

The chemical reactions and pathways resulting in the formation of carnitine (hydroxy-trimethyl aminobutyric acid), a compound that participates in the transfer of acyl groups across the inner mitochondrial membrane.

SHMT1, ALDH9A1

GO:0045332

BP

phospholipid translocation

The movement of a phospholipid molecule from one leaflet of a membrane bilayer to the opposite leaflet.

ATP8B1, ATP9A, ABCA1, ATP8B4, TMEM30A, ATP11B

GO:0045333

BP

cellular respiration

The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).

NDUFS4, NDUFS1, CYCS, NFATC4, NDUFAF2, NR4A3, TBRG4, PPARGC1A, SLC25A13

GO:0045337

BP

farnesyl diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of farnesyl diphosphate.

FDPS

GO:0045338

BP

farnesyl diphosphate metabolic process

The chemical reactions and pathways involving farnesyl diphosphate, an intermediate in carotenoid, sesquiterpene, squalene and sterol biosynthesis, as well as a substrate in protein farnesylation.

FDFT1

GO:0045342

BP

MHC class II biosynthetic process

The chemical reactions and pathways resulting in the formation of major histocompatibility protein class II.

SLC11A1

GO:0045345

BP

positive regulation of MHC class I biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.

NLRC5, HSPH1

GO:0045347

BP

negative regulation of MHC class II biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.

PF4, IL10, MARCH8, HDAC2

GO:0045348

BP

positive regulation of MHC class II biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.

TLR4, XBP1, IL10

GO:0045351

BP

type I interferon biosynthetic process

The chemical reactions and pathways resulting in the formation of any type I interferon. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

IFNAR1

GO:0045355

BP

negative regulation of interferon-alpha biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-alpha.

IL10, NMI

GO:0045356

BP

positive regulation of interferon-alpha biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-alpha.

TLR3

GO:0045358

BP

negative regulation of interferon-beta biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-beta.

NMI

GO:0045359

BP

positive regulation of interferon-beta biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-beta.

TLR4, TLR3, TBK1

GO:0045401

BP

positive regulation of interleukin-3 biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-3.

SYK

GO:0045408

BP

regulation of interleukin-6 biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.

CEBPB

GO:0045409

BP

negative regulation of interleukin-6 biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.

INPP5D, GHSR, GHRL

GO:0045410

BP

positive regulation of interleukin-6 biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-6.

EREG, IL1B, PTAFR, TIRAP, TLR1

GO:0045415

BP

negative regulation of interleukin-8 biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.

KLF4, BCL3, MAP2K5

GO:0045416

BP

positive regulation of interleukin-8 biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.

TLR4, BCL10, TNF, APOA2

GO:0045425

BP

positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of granulocyte macrophage colony-stimulating factor.

SYK

GO:0045429

BP

positive regulation of nitric oxide biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.

TLR4, KLF4, TLR5, JAK2, DDAH1, DDAH2, EGFR, ASS1, AGT, INS, TNF, IL1B, ITGB2, IL6, EDN1, ICAM1, INSR, HSP90AA1, HSP90AB1, CLU, PTX3, AKT1, PTGS2, AGTR2, HBB, SMAD3, PKD2, TRPV1, P2RX4, KLF2

GO:0045444

BP

fat cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat.

TMEM120B, SOCS1, KLF4, SMAD6, GPX1, INHBB, EGR2, IL11, NR4A1, PSMB8, AKT2, GRK5, SREBF1, NR4A2, ID4, CEBPD, GSK3B, HMGA2, SOX8, RNASEL, EP300, FOXO1, ARID5B, STEAP4, NIPBL, BBS7, LRRC8C, NR4A3, SDF4, OSBPL11, BBS2, C1QTNF3, TMEM120A, OSBPL8, WNT5B, RETN, MKKS, PLCB1, TCF7L2, ERAP1, FBXO9

GO:0045445

BP

myoblast differentiation

The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.

HMGCR, IGF1, RB1, LGALS1, DTYMK, JAG1, MBNL1

GO:0045446

BP

endothelial cell differentiation

The process in which a mesodermal, bone marrow or neural crest cell acquires specialized features of an endothelial cell, a thin flattened cell. A layer of such cells lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.

EDF1, HOXB5, S1PR1, JAG1, SCUBE1, BMPER

GO:0045453

BP

bone resorption

The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.

TPP1, TNFSF11, PTH, ADRB2, RAC2, CTNNB1, CTSK, RAB7A, RAC1, ZNF675, NOX4

GO:0045454

BP

cell redox homeostasis

Any process that maintains the redox environment of a cell or compartment within a cell.

KRIT1, AIFM1, GSR, CYBB, IL6, GPX1, P4HB, DLD, TXN, PDIA4, NCF2, NOS3, PRDX6, PDIA3, PRDX2, DDIT3, GLRX, GCLC, SLC11A1, PRDX1, PRDX4, PDIA5, NCF4, PDIA6, TXNRD1, TXNDC11, QSOX2, ERO1B, DNAJC10, NHLRC2, ERO1A, TXNDC15, TXN2, VIMP, ERP44, TMX4, SH3BGRL3, GLRX2, DNAJC16

GO:0045471

BP

response to ethanol

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.

MSTN, GOT2, GNRH1, PENK, PTH, RBP4, BGLAP, HMGCR, NTRK1, TYMS, S100A8, CYP2E1, ICAM1, FYN, CDK1, TH, CA3, CD14, GSTP1, SPARC, G6PD, CCL2, EEF2, ALAD, SLC2A4, NQO1, VCAM1, TRH, CNR1, EEF1B2, TNC, CD27, MAOB, ADH7, STAT3, LEP, ADCYAP1R1, STAR, OXCT1, PTEN, RPL10A, ACTC1, ABAT, HAMP, TJP1, GRIN2A, EIF4EBP1, CASP8, ADIPOQ, CDO1, AACS, SETD7, GGH, BAD, SDF4, PEMT

GO:0045472

BP

response to ether

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ether stimulus.

TH, MDM2

GO:0045475

BP

locomotor rhythm

The rhythm of the locomotor activity of an organism during its 24 hour activity cycle.

USP2, NAGLU, PTEN, ID2, MTA1, NCOA2

GO:0045494

BP

photoreceptor cell maintenance

Any process preventing the degeneration of the photoreceptor, a specialized cell type that is sensitive to light.

MAK, CROCC, DRAM2, BBS12, NPHP3, BBS1, BBS10, GPR98, BBS2, MKKS, SPATA7

GO:0045540

BP

regulation of cholesterol biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.

SEC14L2, APOB, DHCR7

GO:0045541

BP

negative regulation of cholesterol biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.

ERLIN2, APOE

GO:0045542

BP

positive regulation of cholesterol biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.

SREBF1

GO:0045556

BP

positive regulation of TRAIL biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of TRAIL, TNF-related apoptosis inducing ligand.

TNFRSF8

GO:0045576

BP

mast cell activation

The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.

NDRG1

GO:0045577

BP

regulation of B cell differentiation

Any process that modulates the frequency, rate or extent of B cell differentiation.

ZFP36L2, ZFP36L1

GO:0045578

BP

negative regulation of B cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of B cell differentiation.

INHA, INHBA, ID2, SFRP1

GO:0045579

BP

positive regulation of B cell differentiation

Any process that activates or increases the frequency, rate or extent of B cell differentiation.

XBP1, CD27, SYK, MMP14, STAT5B, INPP5D, BAD

GO:0045580

BP

regulation of T cell differentiation

Any process that modulates the frequency, rate or extent of T cell differentiation.

SLC46A2, CYP26B1, PRELID1

GO:0045581

BP

negative regulation of T cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation.

CD74

GO:0045582

BP

positive regulation of T cell differentiation

Any process that activates or increases the frequency, rate or extent of T cell differentiation.

CD74, RAG1, XBP1, IL12A, BAD

GO:0045586

BP

regulation of gamma-delta T cell differentiation

Any process that modulates the frequency, rate or extent of gamma-delta T cell differentiation.

EGR3

GO:0045588

BP

positive regulation of gamma-delta T cell differentiation

Any process that activates or increases the frequency, rate or extent of gamma-delta T cell differentiation.

SYK, STAT5B

GO:0045589

BP

regulation of regulatory T cell differentiation

Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.

CD28, FANCD2

GO:0045590

BP

negative regulation of regulatory T cell differentiation

Any process that stops, prevents, or reduces the rate of differentiation of regulatory T cells.

IRF1, TNFSF4

GO:0045591

BP

positive regulation of regulatory T cell differentiation

Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.

TGFB1, CD46, HLA-G

GO:0045595

BP

regulation of cell differentiation

Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.

KLF4, SPRY2, FADS1, PTBP3, RAF1, FGFR1, APC, PPP2R1A, SIK1, RUNX3, RUNX2, SPOCK2, PLEKHB2, PLEKHB1, TCFL5, EID1

GO:0045596

BP

negative regulation of cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation.

HMGB3, TBX1, GDF11, KRAS, TGFB1, ITGB1, IAPP, SKIL, MAPK1, NR0B1, CDK6, SUZ12, ANP32B, HOPX, ELF5

GO:0045597

BP

positive regulation of cell differentiation

Any process that activates or increases the frequency, rate or extent of cell differentiation.

SOCS3, PAX4, JAK2, INS, JUN, AR, JUNB, JUND, CTGF, BTC, NF2, INSM1, ZNF268, RPS6KA1, PPP1R13L, SOX17, PA2G4

GO:0045598

BP

regulation of fat cell differentiation

Any process that modulates the frequency, rate or extent of adipocyte differentiation.

NR1D1, HES1, MEX3C, LGALS12, HDAC6

GO:0045599

BP

negative regulation of fat cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.

ARNTL, AXIN1, INSIG1, TGFB1, TNF, IL6, ENPP1, MMP11, RORA, DDIT3, WNT5A, ID4, ZFP36L2, JAG1, SMAD3, E2F1, FOXO1, CCDC85B, ADIPOQ, BBS12, SIRT2, ZFPM2, JDP2, TRIB2, TRIB3, GPER1

GO:0045600

BP

positive regulation of fat cell differentiation

Any process that activates or increases the frequency, rate or extent of adipocyte differentiation.

SH3PXD2B, SNAI2, CREBL2, LRP5, BMP2, CREB1, CEBPB, XBP1, ZFP36, HTR2C, AKT1, PPARG, ID2, PPARD, ZBTB16, ZFP36L1, STK4, ADIRF, ASXL2, CARM1, SFRP1, TRPM4, RARRES2, CCDC3, WNT5B, NOCT, WIF1

GO:0045601

BP

regulation of endothelial cell differentiation

Any process that modulates the frequency, rate or extent of endothelial cell differentiation.

APOLD1

GO:0045602

BP

negative regulation of endothelial cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of endothelial cell differentiation.

ID1, XDH

GO:0045603

BP

positive regulation of endothelial cell differentiation

Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation.

BMP4, BMP6, CTNNB1, NOTCH1, BTG1, ATOH8

GO:0045604

BP

regulation of epidermal cell differentiation

Any process that modulates the frequency, rate or extent of epidermal cell differentiation.

MAFG, MAFF

GO:0045605

BP

negative regulation of epidermal cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal cell differentiation.

EZH2

GO:0045606

BP

positive regulation of epidermal cell differentiation

Any process that activates or increases the frequency, rate or extent of epidermal cell differentiation.

BMP4, SFN, PTCH1, SFRP4

GO:0045607

BP

regulation of auditory receptor cell differentiation

Any process that modulates the frequency, rate or extent of auditory hair cell differentiation.

MYCN

GO:0045608

BP

negative regulation of auditory receptor cell differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of auditory hair cell differentiation.

NOTCH1, HES1

GO:0045616

BP

regulation of keratinocyte differentiation

Any process that modulates the frequency, rate or extent of keratinocyte differentiation.

ROCK2, ZFP36, ZFP36L1, AQP3, ERRFI1

GO:0045617

BP

negative regulation of keratinocyte differentiation

Any process that stops, prevents, or reduces the frequency, rate or extent of keratinocyte differentiation.

SRSF6

GO:0045618

BP

positive regulation of keratinocyte differentiation

Any process that activates or increases the frequency, rate or extent of keratinocyte differentiation.

CYP27B1, H2AFY, VDR, NME2, NOTCH1, H2AFY2, NCOA3

GO:0045619

BP

regulation of lymphocyte differentiation

Any process that modulates the frequency, rate or extent of lymphocyte differentiation.

FAS, NDFIP1

GO:0045624

BP

positive regulation of T-helper cell differentiation

Any process that activates or increases the frequency, rate or extent of T-helper cell differentiation.

SHB